TRAVERE THERAPEUTICS, INC. Other Current Liabilities
TRAVERE THERAPEUTICS, INC. (TVTX) had Other Current Liabilities of $2.10 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-04
- 2026-06-30: Other Liabilities, Current $2.10M.
- 2026-03-31: Other Liabilities, Current $2.10M.
- 2025-12-31: Other Liabilities, Current $3.19M.
- 2025-09-30: Other Liabilities, Current $5.35M.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.10M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $2.10M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $3.19M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $5.35M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $14.29M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $15.76M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $17.11M 10-K · filed 2026-02-19 | $14.29M 10-K · filed 2025-02-21 |
| 2024-09-30 | $5.23M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $5.24M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $5.43M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $5.24M 10-K · filed 2025-02-21 | |
| 2023-09-30 | $5.24M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $5.24M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $5.73M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $5.72M 10-K · filed 2024-02-20 | |
| 2022-09-30 | $5.72M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $6.02M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $6.06M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $6.19M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $10.06M 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $8.87M 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $7.34M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $5.98M 10-K · filed 2022-02-24 | $6.33M 10-K · filed 2021-03-01 |
| 2020-09-30 | $6.78M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $7.36M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $8.44M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $8.59M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $8.41M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $8.42M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $8.29M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $6.17M 10-K · filed 2020-02-24 | $4.07M 10-K · filed 2019-02-26 |
| 2018-09-30 | $3.83M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $3.48M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $3.96M 10-Q · filed 2018-07-06 | |
| 2017-12-31 | $3.90M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $4.05M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $1.59M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $1.67M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $1.84M 10-K · filed 2018-07-06 | |
| 2016-09-30 | $1.14M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $1.19M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $1.24M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $958.00K 10-K · filed 2017-03-01 | |
| 2015-09-30 | $1.03M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $897.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $943.62K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $206.00K 10-K · filed 2016-02-26 | $938.21K 10-K · filed 2015-03-11 |
| 2014-09-30 | $774.07K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $588.60K 10-Q · filed 2014-08-14 | |
| 2013-03-31 | $0.00 10-Q/A · filed 2013-09-16 | |
| 2012-12-31 | $11.25K 10-Q/A · filed 2013-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |